.JRMS DECE 2024; 31 (3): 10.12816/0062044.
INTRODUCTION
Congenital heart defect (CHD) is considered as the most common of all birth defects and accounts for around 28% of all congenital anomalies [1]. Significantly, CHD is the major cause of mortality and morbidity in the first year of neonatal life compared with other types of birth defects [2, 3].
Despite recent development and improvement in healthcare services, including diagnosis, interventional, surgical techniques, and management, CHD continues to be a serious health problem worldwide [4, 5]. In 2017, the Global Burden of Disease (GBD) reported that more than 260,000 deaths were associated with CHD globally [6]. Several international studies and reports showed that the incidence rate and prevalence of CHD vary widely from 2 to 13 per 1000 live births [7, 8].
Despite the etiology of most CHD being unknown, numerous studies have reported that CHD has a multifactorial origin and is associated with predisposing risk factors [9, 10]. A review of the literature showed that around 10% of CHDs were linked to genetic abnormality [11], and environmental conditions were associated with 3% [12]. Furthermore, maternal ailments and conditions were reported as significant predisposing risk factors [13, 14]. Younger or advanced maternal age was reported to increase the risk of CHD [15]. Diabetes mellitus is consistently associated with CHD, and it is widely believed that hyperglycemia plays a significant role in inducing malformation during the critical period of organogenesis and embryogenesis [16-18].
Hypertension is a common problem during pregnancy, and untreated hypertension was reported in many studies to increase the risk of CHD by twofold [19, 20]. Obesity and excess weight among potential mothers are strongly associated with higher risk of having an infant with CHD [21, 22]. According to the Baltimore-Washington Infant Study (BWIS) and California Birth Defects Monitoring Program, maternal use of therapeutic drugs such as antidepressant, antihypertensive, and anti-infection medications is associated with increased risk of CHD [23, 24].
According to the Centers for Disease Control and Prevention (CDC) and the National Health Service (NHS), CHD is categorized based on pathophysiology and affected heart structure as acyanotic and cyanotic. Acyanotic lesions include obstructive heart defects (OHD), which are characterized by abnormal narrowing or blocking of heart valves, arteries, or veins [25]. Pulmonary stenosis (PS) is a common example of obstructive heart defects and accounts for 8% of CHDs. Compared to sub-phenotypes of OHD, coarctation of the aorta and aortic stenosis account for 5% and 4%, respectively [26].
Septal heart defects allow blood to flow through the septum between the right and left chambers. They are subdivided into atrial septal defect (ASD) and ventricular septal defect (VSD), which is considered as the most frequent phenotype of all CHDs and cardiac anomalies [27]. While Patent foramen ovale (PFO) is as a result of an incompetent fossa ovalis valve with up to 25% prevalence in the general population [28]. Blood with less than a normal percentage of oxygen can result from cyanotic heart defects such as tetralogy of Fallott, tricuspid atresia, transposition of great arteries, patent ductus arteriosus (PDA), hypoplastic left heart syndrome, truncus arteriosus, and tricuspid atresia [29].
In the Middle East and North Africa, limited reports from government or healthcare providers have been issued about the prevalence of CHD. In Jordan, research and documented data are limited in regard to the pattern and incidence rate of CHDs among the population. Thus, the aim of this study was to assess the pattern, incidence, and gender correlation of detected CHDs in neonatal evaluation during the first week of life at Prince Zeid Ben Al-Hussein Military Hospital in Tafilah. Geographically, Tafilah located in the southern of Jordan at around 180 km southwest of Amman with estimated population of 120,000. Prince Zeid Ben Al-Hussein Military Hospital is the major hospital in Tafilah governate offering medical and clinical services for the population residing in the region.
METHODS
An observational retrospective study was conducted at Prince Zeid Ben Al-Hussein Military Hospital from October 1, 2009, to May 31, 2010. We included all neonates who had 2-dimensional echocardiography reports from neonatal evaluation during the first week of life. The primary variable of interest was the type of diagnosed CHD. 2-dimensional echocardiography was the definitive tool for diagnosis of CHD. The collected data included gender, indications for echocardiography, and types of diagnosed CHD.
All collected data were entered into Microsoft Excel sheets and analyzed by IBM (SPSS) Statistics version 26. The analyzed data were presented as frequency distributions and percentages for categorical variables. A chi-squared test was used to estimate the risk of CHD based on gender, p-value < 0.05 was considered as significant.
RESULTS
A total of 424 neonates were referred for cardiology evaluation and had 2-dimensional echocardiology in the first week of life during the study period. There were 214 (50.5%) males and 210 (49.5%) females. The indications for echocardiology referral are summarized in figure 1. During neonatal evaluation, murmur (33.7%), bluish color of the skin (24.3%), antenatal complications (20.5%), and family history (15.6%) were the leading indications for echocardiology.
Among the total study population referred to echocardiology, CHD was encountered in 275 (64.85%) neonates. The findings of 2-dimensional echocardiography showed that acyanotic CHD lesions were the predominant diagnosis. We found that PDA was the most frequent diagnosis during neonatal evaluation, accounting for 43.4%, followed by ASD at 17.2% and VSD at 4.3%, as shown in figure 2.
Figure 2: Rotating the volume to position the long axis of the mandibular canal parallel to sagittal plane (purple line).
The coronal section (green line) passes through the anterior end of the mental foramen; we started looking for the radiolucencies anterior to this section

Figure 3: Two examples of anterior loops showing as single radiolucency greater than 3mm anterior to the mental foramina

Figure4: An example of measuring the anterior loop length; eight coronal sections (from section 2 to 9) in this case are showing an anterior loop. So as each section thickness is 0.3, and 0.3*8 equals 2.4, the length of the anterior loop is then considered to be 2.4mm.
Ahmad SharadgahMD, Alaa Al TawalbehMD, Mustafa AlhajiMD, Alaeddin Ali SalehMD. Mohammed Al BatainehMD. Pediatric From the departments of:
Pediatric Moh, harbe khassawneh MD From the departments of:
cardiac surgery Yousef Jamal zraigat MD This single-center study has reported on the pattern and incidence of diagnosed CHD among neonates who were referred for cardiology evaluation and had 2-dimentional echocardiology in the first week of life. Our findings showed that PDA was the most commonly diagnosed CHD, followed by ASD and VSD. The obtained pattern and incidence of CHD varied in comparison with other international reports due to the age of included neonates and the study design. Notable differences in the prevalence of total diagnosed CHDs and sub-phenotype lesions based on gender were observed with a female predilection. Multicenter studies based on a national medical registry are suggested, which could play a significant role in evaluating the incidence rate and pattern of CHD in Jordan.
ETHICS APPROVAL
Institutional Review Board (IRB) approval was obtained from the ethics committee at Royal Medical Services. Patients’ data privacy and confidentiality were maintained as this study was conducted in compliance with the ethical standards outlined in the Declaration of Helsinki.
LIMITATIONS
The main limitation of our study is the retrospective nature of single center study in the south of Jordan making it difficult to infer our results at a national level. Multi-centric similar studies are required to be performed in different geographical area of Jordan. In addition, the primary variable of interest was the type of diagnosed CHD by 2-dimensional echocardiography as the definitive tool for diagnosis of CHD. However, no verification mechanism for diagnosis was used.
REFERENCES
1.Dolk, H., et al., Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation, 2011. 123(8): p. 841-849.
2.Marelli, A.J., et al., Congenital heart disease in the general population: changing prevalence and age distribution. Circulation, 2007. 115(2): p. 163-172.
3.Members, W.G., et al., Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation, 2012. 125(1): p. e2-e220.
4.Gilboa, S.M., et al., Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation, 2016. 134(2): p. 101-109.
5.Triedman, J.K. and J.W. Newburger, Trends in congenital heart disease: the next decade. Circulation, 2016. 133(25): p. 2716-2733.
6.Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child Adolesc Health, 2020. 4(3): p. 185-200.
7.Liu, Y., et al., Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. International journal of epidemiology, 2019. 48(2): p. 455-463.
8.Bolisetty, S., et al., Congenital heart defects in Central Australia. Medical journal of Australia, 2004. 180(12): p. 614-617.
9.Haq, F.U., et al., Risk factors predisposing to congenital heart defects. Annals of pediatric cardiology, 2011. 4(2): p. 117.
10.Nabulsi, M.M., et al., Parental consanguinity and congenital heart malformations in a developing country. American journal of medical genetics Part A, 2003. 116(4): p. 342-347.
11.Brent, R.L., Environmental causes of human congenital malformations: the pediatrician’s role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics, 2004. 113(Supplement_3): p. 957-968.
12.Botto, L.D. and A. Correa, Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival. Progress in Pediatric Cardiology, 2003. 18(2): p. 111-121.
13.Nielsen, G.L., et al., Risk of specific congenital abnormalities in offspring of women with diabetes. Diabetic medicine, 2005. 22(6): p. 693-696.
14.Patel, S.S. and T.L. Burns, Nongenetic risk factors and congenital heart defects. Pediatric cardiology, 2013. 34(7): p. 1535-1555.
15.Miller, A., et al., Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. American journal of medical genetics Part A, 2011. 155(9): p. 2137-2145.
16.Chen, H., Diabetic embryopathy. Atlas of Genetic Diagnosis and Counseling, 2006: p. 289-294.
17.Bánhidy, F., et al., Congenital abnormalities in the offspring of pregnant women with type 1, type 2 and gestational diabetes mellitus: A population‐based case‐control study. Congenital anomalies, 2010. 50(2): p. 115-121.
18.Correa, A., et al., Diabetes mellitus and birth defects. Obstetric Anesthesia Digest, 2009. 29(1): p. 40-41.
19.Caton, A.R., et al., Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension, 2009. 54(1): p. 63-70.
20.Li, D.-K., et al., Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. Bmj, 2011. 343.
21.Madsen, N.L., et al., Prepregnancy body mass index and congenital heart defects among offspring: a population‐based study. Congenital heart disease, 2013. 8(2): p. 131-141.
22.Blomberg, M.I. and B. Källén, Maternal obesity and morbid obesity: the risk for birth defects in the offspring. Birth Defects Research Part A: Clinical and Molecular Teratology, 2010. 88(1): p. 35-40.
23.Dietz, H., Epidemiology of congenital heart disease: The baltimore‐washington infant study 1981–1989, C. Ferencz, JD Rubin, CA Loffredo, and CA Magee, eds., Mount Kisco, NY: Futura Publishing Company, 353 pages, $75.00. 1994, Wiley Online Library.
24.Carmichael, S.L. and G.M. Shaw, Maternal life event stress and congenital anomalies. Epidemiology, 2000. 11(1): p. 30-35.
25.Botto, L.D., et al., Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Research Part A: Clinical and Molecular Teratology, 2007. 79(10): p. 714-727.
26.Van Der Linde, D., et al., Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. Journal of the American College of Cardiology, 2011. 58(21): p. 2241-2247.
27.Mostefa-Kara, M., L. Houyel, and D. Bonnet, Anatomy of the ventricular septal defect in congenital heart defects: a random association? Orphanet journal of rare diseases, 2018. 13(1): p. 1-8.
28.Lwin, M.T., T. Branco Mano, and W. Li, ASD or PFO: State-of-the-art echocardiography says it all. International Journal of Cardiology Congenital Heart Disease, 2021. 6: p. 100285.
29.Rapoff, M.A., Strategies for Improving Adherence to Pediatric Medical Regimens. 1999: Springer.
30.Khasawneh, W., et al., Incidence and patterns of congenital heart disease among Jordanian infants, a cohort study from a university tertiary center. Frontiers in pediatrics, 2020. 8: p. 219.
31.Iyad, A., A. Fares, and T. Laila, Incidence of congenital heart disease in jordanian children born at jordan university hospital: a seven-year retrospective study. Jordan Med J, 2017. 51: p. 109-117.
32.Amro, K., Pattern of congenital heart disease in Jordan. Eur J Gen Med, 2009. 6(3): p. 161-165.
33.Majeed-Saidan, M.A., et al., Patterns, prevalence, risk factors, and survival of newborns with congenital heart defects in a Saudi population: a three-year, cohort case-control study. Journal of Congenital Cardiology, 2019. 3(1): p. 1-10.
34.Zaqout, M., et al., Incidence of congenital heart disease in Palestinian children born in the Gaza Strip, occupied Palestinian territory: a cross-sectional study. The Lancet, 2013. 382: p. S36.
35.Al-Fahham, M.M. and Y.A. Ali, Pattern of congenital heart disease among Egyptian children: a 3-year retrospective study. The Egyptian Heart Journal, 2021. 73: p. 1-8.
36.Kula, S., et al., Distribution of congenital heart disease in Turkey. Turkish Journal of Medical Sciences, 2011. 41(5): p. 889-893.
37.Samánek, M., et al., Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children. Pediatr Cardiol, 1989. 10(4): p. 205-11.
38.Tanner, K., N. Sabrine, and C. Wren, Cardiovascular malformations among preterm infants. Pediatrics, 2005. 116(6): p. e833-8.
39.Wren, C., Z. Reinhardt, and K. Khawaja, Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed, 2008. 93(1): p. F33-5.
40.Egbe, A., et al., Temporal Variation of Birth Prevalence of Congenital Heart Disease in the U nited S tates. Congenital heart disease, 2015. 10(1): p. 43-50.
41.Ishikawa, T., et al., Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns. Acta Paediatrica, 2011. 100(8): p. e55-e60.
42.Sampayo, F. and F.F. Pinto, [The sex distribution of congenital cardiopathies]. Acta Med Port, 1994. 7(7-8): p. 413-8.
43.Reller, M.D., et al., Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. The Journal of pediatrics, 2008. 153(6): p. 807-813.
44.Lim, M., et al., Intermittent ductal patency in healthy newborn infants: demonstration by colour Doppler flow mapping. Archives of disease in childhood, 1992. 67(10 Spec No): p. 1217-1218.
45.Narayen, I.C., et al., Aspects of pulse oximetry screening for critical congenital heart defects: when, how and why? Archives of Disease in Childhood-Fetal and Neonatal Edition, 2016. 101(2): p. F162-F167.
46.Šamánek, M., et al., Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children. Pediatric cardiology, 1989. 10: p. 205-211.
47.Wren, C., Z. Reinhardt, and K. Khawaja, Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Archives of Disease in Childhood-Fetal and Neonatal Edition, 2008. 93(1): p. F33-F35.
48.Tanner, K., N. Sabrine, and C. Wren, Cardiovascular malformations among preterm infants. Pediatrics, 2005. 116(6): p. e833-e838.